CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PATH-FOR-YOUNG aims to improve treatment decisions for premenopausal women with high-risk breast cancer by validating a gene-expression assay. This project seeks to reduce the burden of chemotherapy while maintaining quality of life through a large-scale clinical trial.
Worldwide, ~7 million women live with or beyond Breast Cancer (BC), as 10-year survival rates exceeding 80% for early-stage (I-III) BC.
Premenopausal BC accounts for 25% in the EU and 55% in low/middle income countries.
Most premenopausal women with BC have high risk of recurrence, therefore standard treatment includes adjuvant chemo- (CT) and endocrine therapy (ET).
However, treatment has substantial physical, emotional and social burden, which is often more pressing for younger compared to old…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
Italy, Torino
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Anderlecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
